Pages that link to "Q36051330"
Jump to navigation
Jump to search
The following pages link to Predicting the 10 year risk of cardiovascular disease in the United Kingdom: independent and external validation of an updated version of QRISK2 (Q36051330):
Displaying 50 items.
- Cardiovascular screening to reduce the burden from cardiovascular disease: microsimulation study to quantify policy options (Q24658434) (← links)
- Ethnicity and prediction of cardiovascular disease: performance of QRISK2 and Framingham scores in a U.K. tri-ethnic prospective cohort study (SABRE--Southall And Brent REvisited) (Q28602638) (← links)
- Critical appraisal and data extraction for systematic reviews of prediction modelling studies: the CHARMS checklist (Q30860218) (← links)
- Predicting dementia risk in primary care: development and validation of the Dementia Risk Score using routinely collected data (Q31038971) (← links)
- Time trends in the prescription of statins for the primary prevention of cardiovascular disease in the United Kingdom: a cohort study using The Health Improvement Network primary care data (Q31108693) (← links)
- Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study (Q33717374) (← links)
- Degree of Agreement between Cardiovascular Risk Stratification Tools (Q33728818) (← links)
- Predicting risk of upper gastrointestinal bleed and intracranial bleed with anticoagulants: cohort study to derive and validate the QBleed scores (Q33960850) (← links)
- The performance of seven QPrediction risk scores in an independent external sample of patients from general practice: a validation study (Q34144933) (← links)
- Predicted 10-year risk of cardiovascular disease is influenced by the risk equation adopted: a cross-sectional analysis. (Q34237508) (← links)
- Prediction of cardiovascular risk using Framingham, ASSIGN and QRISK2: how well do they predict individual rather than population risk? (Q34277995) (← links)
- Predicting non return to work after orthopaedic trauma: the Wallis Occupational Rehabilitation RisK (WORRK) model (Q35144323) (← links)
- Development and validation of risk prediction algorithms to estimate future risk of common cancers in men and women: prospective cohort study (Q35204017) (← links)
- Quantifying the contribution of statins to the decline in population mean cholesterol by socioeconomic group in England 1991 - 2012: a modelling study (Q35347493) (← links)
- Comparing the effectiveness of an enhanced MOtiVational intErviewing InTervention (MOVE IT) with usual care for reducing cardiovascular risk in high risk subjects: study protocol for a randomised controlled trial (Q35441481) (← links)
- Multivariate meta-analysis of individual participant data helped externally validate the performance and implementation of a prediction model. (Q35682635) (← links)
- A Multistep Maturity Model for the Implementation of Electronic and Computable Diagnostic Clinical Prediction Rules (eCPRs) (Q35955740) (← links)
- Development and validation of risk prediction equations to estimate future risk of heart failure in patients with diabetes: a prospective cohort study (Q36053654) (← links)
- Prospective association of the Mediterranean diet with cardiovascular disease incidence and mortality and its population impact in a non-Mediterranean population: the EPIC-Norfolk study (Q36146658) (← links)
- Survival Benefits of Statins for Primary Prevention: A Cohort Study (Q36197713) (← links)
- Cardiometabolic health, prescribed antipsychotics and health-related quality of life in people with schizophrenia-spectrum disorders: a cross-sectional study (Q36198276) (← links)
- Development and validation of risk prediction equations to estimate future risk of blindness and lower limb amputation in patients with diabetes: cohort study (Q36271785) (← links)
- The UK Pharmacy Care Plan service: Description, recruitment and initial views on a new community pharmacy intervention (Q36331766) (← links)
- Net benefit approaches to the evaluation of prediction models, molecular markers, and diagnostic tests (Q36495833) (← links)
- Sample size considerations for the external validation of a multivariable prognostic model: a resampling study (Q36536706) (← links)
- Derivation and validation of QStroke score for predicting risk of ischaemic stroke in primary care and comparison with other risk scores: a prospective open cohort study (Q36811082) (← links)
- External validation of clinical prediction models using big datasets from e-health records or IPD meta-analysis: opportunities and challenges (Q37028590) (← links)
- Development and validation of a predicting model of all-cause mortality in patients with type 2 diabetes (Q37106533) (← links)
- Quantifying the impact of different approaches for handling continuous predictors on the performance of a prognostic model (Q37261771) (← links)
- The efficiency of cardiovascular risk assessment: do the right patients get statin treatment? (Q37267648) (← links)
- Long-term prediction of major coronary or ischaemic stroke event in a low-incidence Southern European population: model development and evaluation of clinical utility (Q37317279) (← links)
- Marginal role for 53 common genetic variants in cardiovascular disease prediction (Q37398952) (← links)
- Cohort study investigating the relationship between cholesterol, cardiovascular risk score and the prescribing of statins in UK primary care: study protocol (Q37454415) (← links)
- Retrospective examination of lipid-lowering treatment patterns in a real-world high-risk cohort in the UK in 2014: comparison with the National Institute for Health and Care Excellence (NICE) 2014 lipid modification guidelines. (Q37654298) (← links)
- Stroke and bleeding risk in atrial fibrillation: navigating the alphabet soup of risk-score acronyms (CHADS2 , CHA2 DS2 -VASc, R2 CHADS2 , HAS-BLED, ATRIA, and more). (Q38244278) (← links)
- Frequency of eating home cooked meals and potential benefits for diet and health: cross-sectional analysis of a population-based cohort study. (Q38619623) (← links)
- BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatment. (Q38826206) (← links)
- Towards better clinical prediction models: seven steps for development and an ABCD for validation (Q39180614) (← links)
- Multiple health behaviour change interventions for primary prevention of cardiovascular disease in primary care: systematic review and meta-analysis (Q39376695) (← links)
- Development and validation of a risk-prediction algorithm for the recurrence of panic disorder (Q41213247) (← links)
- Development and validation of QMortality risk prediction algorithm to estimate short term risk of death and assess frailty: cohort study. (Q41870535) (← links)
- Development of a questionnaire to evaluate patients' awareness of cardiovascular disease risk in England's National Health Service Health Check preventive cardiovascular programme. (Q42368610) (← links)
- Reconsidering lactate as a sepsis risk biomarker (Q42369456) (← links)
- Chronic disease prevention in primary care: how and when will genomics impact? (Q42712725) (← links)
- Cardiovascular risk prediction: balancing complexity against simple practicality (Q43079208) (← links)
- Multicentre observational study of performance variation in provision and outcome of emergency appendicectomy (Q43413818) (← links)
- Contribution of glomerular filtration rate to 10-year cardiovascular and mortality risk among hypertensive adults: Tehran lipid and glucose study (Q44231095) (← links)
- Ratios of leptin to insulin and adiponectin to endothelin are sex-dependently associated with extent of coronary atherosclerosis. (Q45036053) (← links)
- Ethnic group differences in cardiovascular risk assessment scores: national cross-sectional study. (Q46003967) (← links)
- Development and validation of QDiabetes-2018 risk prediction algorithm to estimate future risk of type 2 diabetes: cohort study (Q47162951) (← links)